Found: 14
Select item for more details and to access through your institution.
Effective T‐cell replete haploidentical stem cell transplantation for pediatric patients with high‐risk hematologic disorders.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 3, p. 305, doi. 10.1111/ejh.13906
- By:
- Publication type:
- Article
Geographical and ecological analyses of multiple myeloma in Denmark: Identification of potential hotspot areas and impact of urbanisation.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 3, p. 289, doi. 10.1111/ejh.13904
- By:
- Publication type:
- Article
Progressive multifocal leukoencephalopathy in multiple myeloma.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 3, p. 322, doi. 10.1111/ejh.13909
- By:
- Publication type:
- Article
Optimal timing of molecular monitoring after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 3, p. 330, doi. 10.1111/ejh.13907
- By:
- Publication type:
- Article
Amp(1q) and tetraploidy are commonly acquired chromosomal abnormalities in relapsed multiple myeloma.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 3, p. 296, doi. 10.1111/ejh.13905
- By:
- Publication type:
- Article
Evaluation of the Mayo Additive Staging System in patients with newly diagnosed multiple myeloma: A real‐world analysis.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 3, p. 229, doi. 10.1111/ejh.13897
- By:
- Publication type:
- Article
Bone marrow expression of CD68/CD163 macrophages, IL‐17 and FOXP3 cells in aplastic anemia and their relation to prognosis.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 3, p. 313, doi. 10.1111/ejh.13908
- By:
- Publication type:
- Article
Sutimlimab provides clinically meaningful improvements in patient‐reported outcomes in patients with cold agglutinin disease: Results from the randomised, placebo‐controlled, Phase 3 CADENZA study.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 3, p. 280, doi. 10.1111/ejh.13903
- By:
- Publication type:
- Article
Cost‐effectiveness of recombinant factor VIII Fc versus emicizumab for prophylaxis in adults and adolescents with haemophilia A without inhibitors in the UK.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 3, p. 262, doi. 10.1111/ejh.13901
- By:
- Publication type:
- Article
Effectiveness of progressive moderate‐vigorous intensity elastic resistance training on quality of life and perceived functional abilities in people with hemophilia: Secondary analysis of a randomized controlled trial.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 3, p. 253, doi. 10.1111/ejh.13900
- By:
- Publication type:
- Article
Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC‐Dutch late effects cohort‐linked data.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 3, p. 243, doi. 10.1111/ejh.13899
- By:
- Publication type:
- Article
Occult ischemic bone lesions in children with sickle cell disease: A study of prevalence.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 3, p. 236, doi. 10.1111/ejh.13898
- By:
- Publication type:
- Article
Plasma levels of E‐selectin are associated with retinopathy in sickle cell disease.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 3, p. 271, doi. 10.1111/ejh.13902
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 3, p. 227, doi. 10.1111/ejh.13793
- Publication type:
- Article